This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Jul;25(13):1089-90.

doi: 10.1016/j.ehj.2004.04.035.

New hope for the prevention of recurrent atrial fibrillation

Raed H Abdelhadi, Mina K Chung, David R Van Wagoner

PMID: 15231364
DOI: 10.1016/j.ehj.2004.04.035

Editorial

New hope for the prevention of recurrent atrial fibrillation

Raed H Abdelhadi et al. Eur Heart J. 2004 Jul.

. 2004 Jul;25(13):1089-90.

doi: 10.1016/j.ehj.2004.04.035.

Authors

Raed H Abdelhadi, Mina K Chung, David R Van Wagoner

PMID: 15231364
DOI: 10.1016/j.ehj.2004.04.035

No abstract available

PubMed Disclaimer

Comment in

Anti-inflammatory medication for atrial fibrillation.
Katritsis DG. Katritsis DG. Eur Heart J. 2004 Oct;25(19):1762. doi: 10.1016/j.ehj.2004.08.003. Eur Heart J. 2004. PMID: 15451158 No abstract available.

Comment on

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.
Dernellis J, Panaretou M. Dernellis J, et al. Eur Heart J. 2004 Jul;25(13):1100-7. doi: 10.1016/j.ehj.2004.04.025. Eur Heart J. 2004. PMID: 15231367 Clinical Trial.

Similar articles

[C-reactive protein and atrial fibrillation. An old marker looking for a new target].
Hernández Madrid A. Hernández Madrid A. Rev Esp Cardiol. 2006 Feb;59(2):94-8. Rev Esp Cardiol. 2006. PMID: 16540029 Spanish. No abstract available.
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.
Boos CJ, Lip GY. Boos CJ, et al. J Am Coll Cardiol. 2006 Feb 21;47(4):889-90; author reply 890-1. doi: 10.1016/j.jacc.2005.11.033. Epub 2006 Jan 26. J Am Coll Cardiol. 2006. PMID: 16487864 No abstract available.
Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.
Dernellis J, Panaretou M. Dernellis J, et al. Eur Heart J. 2004 Jul;25(13):1100-7. doi: 10.1016/j.ehj.2004.04.025. Eur Heart J. 2004. PMID: 15231367 Clinical Trial.
[The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
Zyśko D, Gajek J, Mazurek W. Zyśko D, et al. Pol Merkur Lekarski. 2005 Feb;18(104):227-8. Pol Merkur Lekarski. 2005. PMID: 17877137 Review. Polish.
Is atrial fibrillation an inflammatory disorder?
Boos CJ, Anderson RA, Lip GY. Boos CJ, et al. Eur Heart J. 2006 Jan;27(2):136-49. doi: 10.1093/eurheartj/ehi645. Epub 2005 Nov 8. Eur Heart J. 2006. PMID: 16278230 Review.

See all similar articles

Cited by

Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.
Mayyas F, Alzoubi KH, Van Wagoner DR. Mayyas F, et al. Int J Cardiol. 2013 Oct 15;168(6):5135-42. doi: 10.1016/j.ijcard.2013.08.022. Epub 2013 Aug 15. Int J Cardiol. 2013. PMID: 23993726 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information